Regulatory identification of BPA as an endocrine disruptor: Context and methodologyClaire Beausoleil, Cécile Michel, Claude Emond et al.|Molecular and Cellular Endocrinology|2018Cited by 119
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, C. Bélizna, V. Queyrel et al.|The Lancet Rheumatology|2022Cited by 24